Picture of Cellebrite DI logo

CLBT — Cellebrite DI News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapHigh Flyer

Israel's Cellebrite Q2 revenue slightly misses estimates

Israel's Cellebrite Q2 revenue slightly misses estimates


Overview

  • Israel digital intelligence firm's Q2 revenue rose 16% yr/yr, slightly missing analyst expectations

  • Adjusted EPS for Q2 was $0.11


Outlook

  • Cellebrite expects full-year 2026 ARR outlook to $550 mln–$560 mln

  • Company expects full-year 2026 revenue forecast to $555 mln–$561 mln

  • Cellebrite expects full-year 2026 adjusted EBITDA target to $153 mln–$159 mln


Result Drivers

  • LONGER SALES CYCLES - Co said elongated sales cycles contributed to ARR coming in below expectations

  • INSEYETS CONVERSIONS - Co said expansion from Inseyets conversions was less than anticipated, impacting ARR

  • NEW PRODUCT ADOPTION - Co said newer products are making tangible progress, but near-term contribution is limited by elongated sales cycles and timing of additional launches


Company press release: ID:nPn29nkkla


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Slight Miss*

$131.10 mln

$131.87 mln (8 Analysts)

Q2 Adjusted EPS

$0.11

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the software peer group is "buy"

  • Wall Street's median 12-month price target for Cellebrite DI Ltd is $21.00, about 37.7% above its August 12 closing price of $15.25

  • The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 23 three months ago


Reuters Recommended Reads

  • Aug 12 - Israel's Allot Q2 revenue tops estimates, raises 2026 outlook

  • Aug 12 - Israel's Radcom Q2 revenue falls 33% on deployment delays

  • Aug 11 - Cybersecurity firm Intrusion's Q2 revenue falls 22% yr/yr on government contract delays


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Cellebrite DI

See all news